Supplementation of oil-based inactivated H9N2 vaccine with M2e antigen enhances resistance against heterologous H9N2 avian influenza virus infection

Veterinary Microbiology

Volumn 169, Issue 3-4, 2014, Pages 211-217

  Park, Jae Keun ^a   Lee, Dong Hun ^a   Cho, Chung Hwan ^b   Yuk, Seong Su ^a   To, Erdene Ochir ^a   Kwon, Jung Hoon ^a   Noh, Jin Yong ^a   Kim, Byoung Yoon ^a   Choi, Soo Won ^a   Shim, Byoung Shik ^b   Song, Man Ki ^b   Lee, Joong Bok ^a   Park, Seung Yong ^a   Choi, In Soo ^a   Song, Chang Seon ^a  

^a Konkuk University   (South Korea)

^b International Vaccine Institute   (South Korea)

Author keywords

Avian influenza; Chicken; H9N2; M2e; Vaccine

Indexed keywords

AVIAN INFLUENZA; CHICKEN; H9N2; M2E; VACCINE;

ANIMALS; ANTIGENS, VIRAL; CHICKENS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEMAGGLUTINATION INHIBITION TESTS; INFLUENZA A VIRUS, H9N2 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA VACCINES; RECOMBINANT PROTEINS; SPECIFIC PATHOGEN-FREE ORGANISMS; VACCINATION; VACCINES, INACTIVATED;

EID: 84894272948     PISSN: 03781135     EISSN: 18732542     Source Type: Journal    
DOI: 10.1016/j.vetmic.2014.01.001     Document Type: Article

References (25)

1. Alexander D.J. An overview of the epidemiology of avian influenza. Vaccine 2007, 25:5637-5644.
2. Babapoor S., Neef T., Mittelholzer C., Girshick T., Garmendia A., Shang H., Khan M.I., Burkhard P. A novel vaccine using nanoparticle platform to present immunogenic M2e against avian influenza infection. Influenza Res. Treat. 2011, 2011:126794.
3. Choi J.G., Lee Y.J., Kim Y.J., Lee E.K., Jeong O.M., Sung H.W., Kim J.H., Kwon J.H. An inactivated vaccine to control the current H9N2 low pathogenic avian influenza in Korea. J. Vet. Sci. 2008, 9:67-74.
4. Fiers W., De Filette M., El Bakkouri K., Schepens B., Roose K., Schotsaert M., Birkett A., Saelens X. M2e-based universal influenza A vaccine. Vaccine 2009, 27:6280-6283.
5. Fusaro A., Monne I., Salviato A., Valastro V., Schivo A., Amarin N.M., Gonzalez C., Ismail M.M., Al-Ankari A.R., Al-Blowi M.H., Khan O.A., Maken Ali A.S., Hedayati A., Garcia Garcia J., Ziay G.M., Shoushtari A., Al Qahtani K.N., Capua I., Holmes E.C., Cattoli G. Phylogeography and evolutionary history of reassortant H9N2 viruses with potential human health implications. J. Virol. 2011, 85:8413-8421.
6. Herve P.L., Raliou M., Bourdieu C., Dubuquoy C., Petit-Camurdan A., Bertho N., Eleouet J.F., Chevalier C., Riffault S. A novel subnucleocapsid nanoplatform for mucosal vaccination against influenza virus that targets the ectodomain of matrix protein 2. J. Virol. 2014, 88:325-338.
7. Homme P.J., Easterday B.C. Avian influenza virus infections. I. Characteristics of influenza A-turkey-Wisconsin-1966 virus. Avian Dis. 1970, 14:66-74.
8. Kayali G., Kandeil A., El-Shesheny R., Kayed A.S., Gomaa M.R., Kutkat M.A., Debeauchamp J., McKenzie P.P., Webster R.G., Webby R.J., Ali M.A. Do commercial avian influenza H5 vaccines induce cross-reactive antibodies against contemporary H5N1 viruses in Egypt?. Poultry Sci. 2013, 92:114-118.
9. Layton S.L., Kapczynski D.R., Higgins S., Higgins J., Wolfenden A.D., Liljebjelke K.A., Bottje W.G., Swayne D., Berghman L.R., Kwon Y.M., Hargis B.M., Cole K. Vaccination of chickens with recombinant Salmonella expressing M2e and CD154 epitopes increases protection and decreases viral shedding after low pathogenic avian influenza challenge. Poultry Sci. 2009, 88:2244-2252.
10. Lee D.H., Park J.K., Lee Y.N., Song J.M., Kang S.M., Lee J.B., Park S.Y., Choi I.S., Song C.S. H9N2 avian influenza virus-like particle vaccine provides protective immunity and a strategy for the differentiation of infected from vaccinated animals. Vaccine 2011, 29:4003-4007.
11. Lee D.H., Song C.S. H9N2 avian influenza virus in Korea: evolution and vaccination. Clin. Exp. Vaccine Res. 2013, 2:26-33.
12. Lee Y.N., Lee D.H., Park J.K., Lim T.H., Youn H.N., Yuk S.S., Lee Y.J., Mo I.P., Sung H.W., Lee J.B., Park S.Y., Choi I.S., Song C.S. Isolation and characterization of a novel H9N2 influenza virus in Korean native chicken farm. Avian Dis. 2011, 55:724-727.
13. Ma J.H., Yang F.R., Yu H., Zhou Y.J., Li G.X., Huang M., Wen F., Tong G. An M2e-based synthetic peptide vaccine for influenza A virus confers heterosubtypic protection from lethal virus challenge. Virol. J. 2013, 10:227.
14. Park K.J., Kwon H.I., Song M.S., Pascua P.N., Baek Y.H., Lee J.H., Jang H.L., Lim J.Y., Mo I.P., Moon H.J., Kim C.J., Choi Y.K. Rapid evolution of low-pathogenic H9N2 avian influenza viruses following poultry vaccination programmes. J. Gen Virol. 2011, 92:36-50.
15. Perdue M.L., Swayne D.E. Public health risk from avian influenza viruses. Avian Dis. 2005, 49:317-327.
16. Shim B.S., Choi Y.K., Yun C.H., Lee E.G., Jeon Y.S., Park S.M., Cheon I.S., Joo D.H., Cho C.H., Song M.S., Seo S.U., Byun Y.H., Park H.J., Poo H., Seong B.L., Kim J.O., Nguyen H.H., Stadler K., Kim D.W., Hong K.J., Czerkinsky C., Song M.K. Sublingual immunization with M2-based vaccine induces broad protective immunity against influenza. PLoS ONE 2011, 6:e27953.
17. Song J.M., Van Rooijen N., Bozja J., Compans R.W., Kang S.M. Vaccination inducing broad and improved cross protection against multiple subtypes of influenza A virus. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:757-761.
18. Spackman E., Senne D.A., Bulaga L.L., Myers T.J., Perdue M.L., Garber L.P., Lohman K., Daum L.T., Suarez D.L. Development of real-time RT-PCR for the detection of avian influenza virus. Avian Dis. 2003, 47:1079-1082.
19. Sun Y., Pu J., Fan L., Sun H., Wang J., Zhang Y., Liu L., Liu J. Evaluation of the protective efficacy of a commercial vaccine against different antigenic groups of H9N2 influenza viruses in chickens. Vet. Microbiol. 2012, 156:193-199.
20. Webster R.G., Webby R.J., Hoffmann E., Rodenberg J., Kumar M., Chu H.J., Seiler P., Krauss S., Songserm T. The immunogenicity and efficacy against H5N1 challenge of reverse genetics-derived H5N3 influenza vaccine in ducks and chickens. Virology 2006, 351:303-311.
21. Wood J.M., Kawaoka Y., Newberry L.A., Bordwell E., Webster R.G. Standardization of inactivated H5N2 influenza vaccine and efficacy against lethal A/Chicken/Pennsylvania/1370/83 infection. Avian Dis. 1985, 29:867-872.
22. Zhang X., Liu M., Liu C., Du J., Shi W., Sun E., Li H., Li J., Zhang Y. Vaccination with different M2e epitope densities confers partial protection against H5N1 influenza A virus challenge in chickens. Intervirology 2011, 54:290-299.
23. Zhang Y., Yin Y., Bi Y., Wang S., Xu S., Wang J., Zhou S., Sun T., Yoon K.J. Molecular and antigenic characterization of H9N2 avian influenza virus isolates from chicken flocks between 1998 and 2007 in China. Vet. Microbiol. 2012, 156:285-293.
24. Zhang Z., Li Y., Xu S., Chen F., Zhang L., Jiang B., Chen X. Fusion to chicken C3d enhances the immunogenicity of the M2 protein of avian influenza virus. Virol. J. 2010, 7:89.
25. Zhao G., Lin Y., Du L., Guan J., Sun S., Sui H., Kou Z., Chan C.C., Guo Y., Jiang S., Zheng B.J., Zhou Y. An M2e-based multiple antigenic peptide vaccine protects mice from lethal challenge with divergent H5N1 influenza viruses. Virol. J. 2010, 7:9.